Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial

K Weisel, M Dimopoulos, KW Song, P Moreau, A Palumbo, A Belch, S Schey, Pieter Sonneveld, L Sternas, X Yu, R Amatya, C J Gibson, M Zaki, C Jacques, J San Miguel

Research output: Contribution to journalArticleAcademicpeer-review

39 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)519-530
Number of pages12
JournalClinical Lymphoma Myeloma & Leukemia
Issue number9
Publication statusPublished - 2015

Cite this